Hepatitis C Virus
History of intravenous drug use strongest predictor for HIV/HCV coinfection
Published in AIDS Weekly, August 2nd, 2004
"The declining incidence of AIDS-related opportunistic diseases among people with HIV infection has shifted the focus of clinical management to prevention and treatment of comorbidities such as chronic liver disease. The increased risk of hepatitis C virus (HCV)-related advanced liver disease in people with HIV infection makes early HCV diagnosis a priority.
"To assess HCV prevalence and predictors of HIV/HCV coinfection, we have conducted a retrospective analysis of people enrolled in the CAESAR (Canada, Australia, Europe, South Africa) study, a multinational...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-08-02)
More Articles from AIDS Weekly
- Antiretroviral Therapy
Styrylquinolines do not interfere with HIV entry but act before integration - HIV/AIDS Research
Species-specific tropism determinants found in the HIV-1 capsid - HIV/AIDS Therapy
Subcutaneous IL-2 therapy maintains CD4 cell increases in HIV-1 infection - HIV/AIDS-Related Disease
BCL-6 mutations seen in HIV-related pulmonary lymphoproliferative disorders - HIV/AIDS-Related Disease
HAART increases survival of patients with HIV-associated Hodgkin disease - AIDS Therapy
Up-front cost for treating HIV-infected patient in Africa is US$30 per visit - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
